Roberta Venturella

ORCID: 0000-0003-1359-770X · 36 papers in corpus
2014
CA125 and VAS Pain Score Modifications Following GnRH-Analog Administration as Ex Adiuvantibus Criteria to Diagnose Endometriosis as Cause of Chronic Pelvic Pain
·doi:10.1016/j.jmig.2014.08.457
2014
Periostin Expression Is Related to the Invasive Tumor-Like Phenotype of Endometriosis: A New Promising Biomarker to Use in Risk Stratification of Patients
·doi:10.1016/j.jmig.2014.08.058
case-report 2013
An Unusual Extremely Distant Noncommunicating Uterine Horn with Myoma and Adenomyosis Treated with

Copyright © 2013 Michele Morelli et al.This is an open access article distributed under the Creative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is pro…

case-report 2013
An unusual extremely distant noncommunicating uterine horn with myoma and adenomyosis treated with laparoscopic hemihysterectomy
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2013/160291

A 41-year-old woman referred to us with dysmenorrhea and severe pelvic pain although she was previously submitted to right laparotomic adnexectomy for ovarian endometrioma and to a subsequent operative laparoscopy for pelvic adhesions. Afte…

2013
An Unusual Extremely Distant Non-Communicating Uterine Horn with Myoma and Adenomyosis Treated with Laparoscopic Hemy-Hysterectomy
·doi:10.1016/j.jmig.2013.08.647
other 2013
Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513590.2012.743017

The aim of this study was to evaluate the improvement in catamenial chronic pelvic pain (CPP) after Gonadotropin Releasing Hormone analogue (GnRH-a) administration in women affected by adenomyosis or endometriosis. We retrospectively analys…

other 2013
Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.12030

AIM: In recent years, both dienogest, a fourth-generation progestin, and levonorgestrel-releasing intrauterine device have been found to be effective in terms of endometriosis-related pelvic pain improvement. No data, however, are available…

2013
The importance of treating pain in endometriosis
·doi:10.1586/17474108.2013.825467

Department of Obstetrics & Gynecology, “Magna Graecia” University, Gynecologic Oncology Unit, “Tommaso Campanella” Cancer Center of Germaneto, viale Europa, loc. Germaneto, 88100 Catanzaro “It is important to emphasize that in women undergo…

2012
Letrozole vs. Clomiphene Citrate Plus IUI for Women Recently Surgically Treated for Severe or Recurrent Endometriosis: A Randomized Controlled Trial
·doi:10.1016/j.jmig.2012.08.146
2012
Prophylactic Salpingectomy Does Not Affect Short and Long Term Surgical Outcomes When Associated to Surgery for Benign Indications
·doi:10.1016/j.jmig.2012.08.136
diagnostic-accuracy 2011
CA 125 Modifications Throughout Menstrual Cycle and following GnRH-Analog Administration to Diagnose Endometriosis as Cause of Chronic Pelvic Pain. A Prospective Controlled Study
·doi:10.5301/je.2011.8911

Purpose Endometriosis is the leading single cause of chronic pelvic pain (CPP). To date, the gold standard to diagnose this condition is histologic confirmation of lesions obtained by surgery. However, a noninvasive and cheaper tool for ear…